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ABSTRACT
Introduction: In the last thirty years, interests in searching for plants with potential antimi-
crobial and antioxidant activities have been increased due to their probable health benefits. 
This study aimed to investigate the antimicrobial and antioxidant effects of various solvents 
fractions of Bupleurum lancifolium. Methods: The antioxidant activities of four fractions of Bu-
pleurum lancifolium were assessed by 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging assay, 
while the antimicrobial activity was assessed by broth microdilution method. The antimicro-
bial activity of four plant fractions was examined against Staphylococcus aureus, Escherich-
ia coli, Pseudomonas aeruginosa, Shigella sonnie and Enterococcus faecium American Type 
Culture Collection reference strains. Results: The fractionation extraction method succeeds 
in the assessment of the antibacterial and antioxidant activity of B. lancifolium plant. Hence 
the methanolic fraction has antioxidant potential with 33.03% of inhibition according to the 
Trolox antioxidant standard molecule, while n-hexane and methanol fractions showed power-
ful antibacterial activity against E. faecium and S. sonnie strains with Minimum Inhibitory Con-
centration (MIC)1.5625 mg/ml for both fractions. Conclusion: All plant fractions have potent 
antioxidant and antibacterial activities. Further investigations, i.e. isolation, identification, and 
clinical assessment, of the active compound(s) are needed for the possible formulation of new 
therapeutic alternatives.
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INTRODUCTION
Herbal remedies have been used as therapeutic agents for thou-
sands of years and utilized in various forms such as powders, 
infusions, tinctures, poultices, and decoctions [1, 2]. The dis-
covery of medications from medicinal plants started with the 
isolation of single active molecules such as salicylic acid, mor-
phine cocaine, atropine, codeine, digoxin, quinine, vincristine 
and quinine, and most of these drugs are still in use [3, 4]. 
However, the developing techniques in chemical drugs synthe-
sis led to a major reduction in the usage of herbal products and 
there was concern that the use of some herbal medications for 
therapeutic purposes might be a banned. However, phytogenic 
products are still important for investigating new medications 
especially for the incurable diseases on which chemical drugs 
failed in their treatment. For example, some kinds of therapeu-
tic agents for certain types of diseases, such as antihypertensive, 
antimalarial, anticancer, and anti-migraine medication, have 
benefited greatly from natural products [5, 6].
Herbals and other natural products derived drugs continue to 
provide phytochemists with valuable pharmacologically active 
compounds and/or chemical models that utilized as starting 
molecules for developing of new medications. In addition, 
more than 80% of the used drugs nowadays are produced from 
natural products and/or inspired by a natural compound [7, 8]. 
Globally estimated about 100 million species or organisms 
living on earth and higher plants forming a group of some 
250,000 species out of which only 6% has investigated for 
biological activities and 15% for their chemical constituents. 
This means that the scientists investigated only little amounts 
of research from the world huge natural products resources [7]. 
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In nature, there are about 190 plants species of Bupleurum 
plant genus that distributed in the North Temperate regions 
mainly in North Africa, Mediterranean, and Eurasia. The Bu-
pleurum plant genus considered as one of the largest genera of 
the family Apiaceae. These plants species are easily recognized 
by their parallel venation of the leaves, conspicuous bracteoles 
and bracts on the inflorescences. On the other hand, pollen 
morphology exhibits little variation in this genus. The fruit 
is ellipsoid or oblong to ovoid-oblong, slightly laterally com-
pressed and their mericarp is subpentagonal and rarely rounded 
in the cross section [9, 10]. Many of Bupleurum plant species 
have been screened to evaluate their content of flavonoid, es-
sential oils, fatty acids as well as the antioxidant properties [11-
14].
The Palestinian flora comprises ten species of Bupleurum, 
which are including Bupleurum boissieri, Bupleurum brevicaule, 
Bupleurum gerardii, Bupleurum libanoticum, Bupleurum nodi-
florum, Bupleurum odontites, Bupleurum orientale, Bupleurum 
semicompositum, Bupleurum subovatum and Bupleurum lanci-
folium [15].
Bupleurum  lancifolium Hornem.  is annual herbaceous plant 
about 10-60 cm height which belongs to the Apiaceae family. 
Its stems divaricately branched from base and striate. The leaves 
are oblong-lanceolate to linear-lanceolate, acuminate, tapering 
at base, while cauline leaves are perfoliate, ovate to ovate-ob-
long or lanceolate with rounded base. Bracteoles are connate 
at base, patulous, ovate to orbicular and mucronate. Flowers 
petals are ovate with truncate or emarginated inflexed apex. Bu-
pleurum lancifolium Fruiting pedicels are thickened and much 
shorter than their fruits. The mericarps are dark brown, promi-
nently ribbed, and densely tuberculate in furrows. 
B. lancifolium is native to Algeria, Austria, Apennine Peninsula, 
Balkan Peninsula, Central Asia, Cyprus, Egypt, Iraq, Iberian 
Peninsula, Libya, Palestine, and Syria. Nowadays it is cultivated 
in Belgium, Luxemburg and British Isles [11, 15].
The leaves of B. lancifolium contain quercetin and isorhamnatin 
flavonoids, while the oil of the seeds contains palmitic, γ-lino-
lenic, linoleic, 1,3-cyclooctadiene and linolenic acids [11].
Bupleurum roots are one of the most frequently used herbs in 
Chinese herbal medicine [16]. The genus Bupleurum contains 
saponin glycoside (Saikosaponins) and polyphenols which have 
potential hepatoprotective agents against acute and chronic he-
patic injury [14]. In folk medicine, some Bupleurum members 
are used in the treatment of various diseases, such as malaria, 
fever, and, influenza [17].
To the best of our knowledge, there is little information about 
the biological and chemical properties of the Bupleurum species 
growing in Palestine. Therefore, more studies on the Bupleurum 
species are necessary. The present paper describes a study un-
dertaken in order to determine antimicrobial and antioxidant 
activities of four solvent fractions B. lancifolium species collect-
ed from the Palestine.
MATERIAL AND METHODS 
Instrumentation 
Shaker device (Memmert, Germany), rotavap (Heidolph, 
Germany), grinder (Moulinex, China), balance (Rad wag, AS 
220/c/2, Poland). lyophilizer (Mill rock technology, China), 
micropipettes (Finnpipette, Finland), incubator (Nuve, Tur-
key), syringe filter 0.45 µm pore size (Microlab, China), mi-
cro-broth plate (Greiner bio-one, Canada), and multi 12-chan-
nel micropipette (Eppendorf, Germany). 
Chemical Reagents
Ethanol, sodium hydroxide, n-hexane, and acetic acid were ob-
tained from Lobachemie, India, and FeCl3, Millon’s reagent, 
Benedict’s reagent Dimethyl sulfoxide (DMSO) were acquired 
from Riedeldehan, Germany, and Molish’s reagent, sulfuric 
acid, Iodine solution were obtained from Alfa-Aesar, England. 
Chloroform, DPPH (2,2-Diphenyl-1-picrylhydrazyl), Trolox 
(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) 
and HCl were bought from Sigma-Aldrich, Germany. In ad-
dition, Magnesium ribbon and Ninhydrin solution obtained 
from Alfa Agar, England, Nutrient broth from Himedia, India, 
and BBL Mueller Hinton II broth, Difco Sabouraud Dextrose 
Agar were acquired from Dickinson and company sparks, USA. 
Bacto tryptic soy broth was obtained from Dickinson and com-
pany sparks, USA, and macConkey agar was purchased from 
Himedia Laboratories, India.
Bacterial Isolates
Antibacterial activity of plant extracts was investigated against 
bacterial isolates obtained from American Type Culture Col-
lection. The isolates included Staphylococcus aureus (ATCC 
25923), Escherichia coli (ATCC 25922), Pseudomonas aerugi-
nosa (ATCC 27853), Shigella sonnie (ATCC 25931) and En-
terococcus faecium (ATCC 700221).
Collection and Preparing of Plant Materials
The aerial parts from B. lancifolium plant were collected in June 
2016 from Jerusalem region in West Bank of Palestine. The col-
lected plant was botanically classified by the pharmacognosist 
Dr. Nidal Jaradat, Department of Pharmacy, Faculty of Medi-
cine and Health Sciences, An-Najah National University. The 
shade dried voucher specimen was archived in the Herbarium 
of the Pharmacognosy Laboratory under herbarium number 
Pharm-PCT-447. 
After washing under running water to remove intercalating de-
bris and soil particles, the plant material was shade dried at 
ambient temperature for two weeks. The dried plant material 
was then finely ground using a mechanical grinder and subse-
quently stored in air-tight containers.
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Fractionation of Plant Extracts
The powdered plant material was sequentially macerated in dif-
ferent solvents that having different polarities to achieve serial 
fractional extraction process; beginning by the maceration of 
50 g of powdered plant material in 500 ml n-hexane for 2 days 
with occasional agitation at room temperature. After filtration, 
the solvent removed by using rotary-evaporator under pressure 
at a temperature not exceeding 35°C. After the filtration in the 
first step, the remaining plant material was macerated in 500 
ml acetone and was treated exactly the same as above. The same 
plant material then macerated in 500 ml methanol and was 
treated exactly the same as above. Finally, the same material 
macerated with 500 ml water and this fraction lyophilized by 
using the freeze dryer apparatus.
The percent recovery of the four fractions extracts calculated 
according to the following formula:
% yield extract (% w/w) = A/B X 100
Where;
A = weight of the dried extract.
B = weight of powdered plant material.
The yields for n-hexane, acetone, methanol and aqueous frac-
tions were 2.68% (w/w), 9.8% (w/w), 14.36% (w/w) and 
12.5% (w/w), respectively. 
Phytochemical Analysis 
Preliminary phytochemical analysis of secondary and primary 
metabolic compounds such as cardiac glycosides, flavonoids, 
saponin glycosides, terpenoids proteins, phenols, carbohy-
drates, starch, steroids, reducing sugar, monosaccharide and 
tannins was carried out according to the standard pharmaco-
peia analytical methods. 
Determination of MIC 
Antimicrobial activities of plant fractions were determined by 
micro-broth dilution method according to Forbes et al 2016 
and Wikler 2007 [18, 19]. A volume of 100 µl of Mueller-Hin-
ton broth was pipetted in each well of micro- titration plate. To 
the first well, 100 µl of plant fraction (50 mg/ml) was added 
and 100 µl was transferred from the well to the next well after 
mixing by the micropipette. This procedure was repeated up 
to well number 11 from which 100 µl were discharged after 
mixing. Well number 11 was the negative control of bacterial 
growth and well number 12 was the positive control of bacteri-
al growth. Each plant extract was examined in duplicate. From 
a bacterial suspension (5 × 107 CFU/ml), 1 µl was pipetted to 
all wells except for well number 11. The inoculated plate was 
incubated at 35°C for 24 hours. The lowest concentration of 
plant fraction that inhibited visible bacterial growth was con-
sidered as the MIC.
Free Radical Scavenging Assay Using Trolox as Standard 
Equivalent
A stock solution of a concentration of 100 µg/ml in meth-
anol was firstly prepared for each plant fraction and Trolox 
(standard reference compound). The working solutions at the 
following concen trations (1, 2, 3, 5, 7, 10, 20, 30, 40, 50, 80 
µg/ml) were prepared by diluting from the stock solution with 
methanol.
Then DPPH (free radical to be inhibited) was freshly pre-
pared at a concentration of 0.002% w/v. The DPPH solution 
was mixed with methanol and the above-prepared working 
concentration in a ration of 1:1:1, respectively. The spectro-
photometer was zeroed using methanol as a blank solution. 
The first solution of the series concentration was DPPH with 
methanol only (control solution). The solutions were incubat-
ed in dark for 30 min at room temperature. Afterwards, the 
absorbance readings were recorded at 517 nm. The percentage 
of antioxidant activity of the plant’s fractions and the Trolox 
standard were calculated using the following formula: 
Percentage of inhibition of DPPH activity (%) = (B - S)/B X 
100%
Where:
 B= Absorbance of the control solution, 
 S = Absorbance of the plant fraction. 
The antioxidant half maximal inhibitory concentration (IC50) 
for the plant fractions and Trolox were determined by using 
the BioDataFit fitting program as follows: 
% Inhibition = (Trolox IC50/fractions IC50) X 100%
Statistical Analysis
Free radical scavenging activities of four B. lancifolium frac-
tions were determined in triplicates. The results were expressed 
as means  ±  standard deviation (SD). The obtained data were 
compared and analyzed by using unpaired t-tests. The statis-
tical significance was considered when the p-value was <0.05. 
Statistical significance is expressed in terms of * when the 
p-value < 0.05, ** when the p-value ≤ 0.001, and *** when the 
p-value ≤ 0.0001.
RESULTS 
Phytochemical Screening of Four B. Lancifolium Frac-
tions 
Phytochemical screening tests for the fractions from B. lan-
cifolium plant showed the presence of active phytochemical 
classes including saponin glycosides, carbohydrates, tannins, 
steroids, cardiac glycosides, alkaloids, reducing sugars, phe-
nols, terpenoids, and flavonoids (Table 1).
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Table 1: Phytochemical screening tests of the aqueous, methanolic, acetone and n-hexane fractions from B. lancifo-
lium.
Class
Hexane Acetone Methanol Aqueous
Fraction Fraction Fraction Fraction
Saponin glycoside − − − +
Protein − − − −
Starch + − + −
Phenols − + + +
Carbohydrates + − + −
Tannin − + + +
Steroids + + + +
Reducing sugar + − + −
Monosaccharide + − + −
Terpenoids + + + +
Flavonoid − + + +
Cardiac glycosides + + − −
Free Radical Scavenging Activity
The free radical scavenging activity of the n-hexane (non-po-
lar solvent), methanolic (polar protic solvent), acetone (polar 
aprotic solvent), and aqueous (polar protic solvent) fractions of 
B. lancifolium were tested using the DPPH method with Trolox 
as a reference standard. Concentrations spanned the range of 
1-100 µg/ml from each extract as well as from Trolox. Con-
trol was determined using DPPH diluted in the corresponding 
solvents (aqueous, acetone, methanolic and n-hexane) without 
plant fractions. The obtained results are shown in Figure 1.
Figure 1: Free radical inhibitory effect of four B. lancifolium fractions.
The calculated half maximal inhibitory concentration (IC50) 
of Trolox was 2.18  ±  1.54 µg/ml. The IC50 for the aqueous, 
acetone, methanolic and n-hexane fractions of aerial parts of 
B. lancifolium are shown in Table 2. 
Table 2: IC50 values of the aqueous, acetone, methanolic and n-hexane fractions of B. lancifolium
% of inhibition, ± SDIC50, µg/ml, ± SDFractions 
8.1% ± 1.2126.9 ± 1.11*n-hexane 
1.28 ± 1.55169.8 ± 1.69**Acetone 
33.03 ± 1.096.6 ± 0.99*Methanol 
13.97 ± 1.2215.6 ± 1.04***Aqueous *p-value <0.05, ** when the p-value ≤ 0.001, and *** when the p-value 
≤ 0.0001.
Antibacterial Activity
By using microbroth dilution method, the results showed that 
the four fractions of B. lancifolium plant exhibited the growth 
of bacterial isolates in this study. The highest antibacterial ac-
tivity (the lowest MIC) was caused by both methanolic and 
hexane fractions with MIC 1.5625 mg/ml against S. sonnie 
and E. faecium, while no inhibition was caused by acetone 
against S. aureus and n-hexane fraction against E. coli (Table 
3). 
Table 3. Minimum inhibitory concentrations (MICs) of B. 
lancifolium fractions.
Bacterial
isolates
MIC(mg/ml)
Acetone 
fraction
Aqueous 
fraction
Methanol 
fraction
Hexane 
fraction
S. aureus NI 6.25 12.5 6.25
E. coli 25 6.25 6.25 NI
S. sonnie 6.25 12.5 1.5625 6.25
E. faecium 12.5 25 6.25 1.5625
P. aeruginosa 3.125 3.125 3.125 3.125NI: No inhibition
DISCUSSION
In the present study, B. lancifolium which growing wildly in 
the West Bank area of Palestine was fractioned by using four 
solvents with various levels of polarity and screened qualita-
tively. In addition, their antibacterial and antioxidant activities 
were assessed. To the best of our knowledge, this is the first 
investigation on the phytochemical and biological activities of 
B. lancifolium plant.
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In the last few years, interest in the investigation for natural 
antioxidant and antibacterial products has increased dramati-
cally. Moreover, the in vitro studies of free radical scavenging 
potentials of flavonoids have gained importance due to their 
potential antioxidant activity. Moreover, this class of secondary 
metabolic compounds has been found in all species of Bupleu-
rum genus [20, 21]. Indeed, a study which was conducted by 
Saleh et al. revealed the presence of quercetin and isorhamnatin 
flavonoids in ethanolic extract of B. lancifolium plant [22].
In the last few decades, it has become clear that antibacterial 
agents such as antibiotics are losing their effectiveness due to 
the bacterial resistance [23]. Therefore, there is a continuing 
need to search for new antibacterial compounds. To achieve 
this, natural products have been considered as one of the fun-
damental antibacterial sources.
The antioxidant results here showed that the aerial parts from 
B. lancifolium have antioxidant potentials in various levels of 
inhibition according to the used solvent. Among them, the 
methanolic fraction extract has the highest antioxidant poten-
tial with 33.03% of inhibition activity compared to the refer-
ence standard (Trolox), followed by an aqueous fraction with 
13.97% of inhibition, n-hexane with 8.1% of inhibition while 
the weakest antioxidant was acetone fraction with 1.28% of 
inhibition in comparison with Trolox.
Regarding the antibacterial assessment by using the microbroth 
dilution method, the results showed that the acetone and aque-
ous fractions of B. lancifolium exhibited strongly the P. aeru-
ginosa bacterial growth with the same MIC value 3.125 mg/
ml, while the highest exhibition of the methanolic fraction was 
against S. sonnie with a MIC value of 1.5625 mg/ml. The best 
antibacterial activity for the n-hexane fraction was against E. 
faecium bacterial isolate. 
According to the E. faecium bacteria which can be a high resis-
tant to drugs that acquired its drug resistance by plasmids and 
conjugative transposons, as well as chromosomal genes that 
encoded the resistance. Some strains have become resistant to 
gentamicin, penicillin, vancomycin, tetracycline, teicoplanin, 
and erythromycin. The spread of the disease occurs among pa-
tients in hospitals due to transferring the pathogen by hands or 
medical instruments. 
Moreover, the best antibacterial activity against P. aeruginosa 
bacteria were all fractions with same MIC value 3.125 mg/
ml, while the best antibacterial activity against E. faecium with 
MIC value 1.5625 mg/ml. Furthermore, the best antibacteri-
al activity against S. aureus was for the aqueous and n-hexane 
fractions with the same MIC value 6.25 mg/ml. The best an-
tibacterial activity against E. coli were aqueous and methanol 
fractions with the same MIC value (6.25 mg/ml) and finally 
the best antibacterial activity against S. sonnie was methanol 
fraction with MIC value 1.5625 mg/ml.
A previous investigation on B. lancifolium leaf constituents by 
Shafaghat, reported the presence of palmitic acid, γ-linolenic 
acid, linoleic acid, 1,3-cyclooctadiene and linolenic acid also 
reported that the antioxidant activity of hexane leaves extract 
was 435 µg/ml. The same study showed that the n-hexane ex-
tract of leaves inhibited antimicrobial activity against Bacillus 
subtilis, Staphylococcus epidermidis, Enterococcus faecalis, Staphy-
lococcus aureus, Escherichia coli, Candida albicans and Saccharo-
myces cerevisiae by using disc diffusion method [11]. 
A study conducted by Gevrenova et al. found that IC50 val-
ues for methanol extract of B. affine, B. baldense and B. flavum 
were 116.47 µg/ml, 31.87 µg/ml, and 22.12 µg/ml, respective-
ly [21].
In comparison with other studies conducted on the same Bu-
pleurum species and other species, the presently studied Pales-
tinian B. lancifolium plant showed potential antibacterial and 
antioxidant activities more than other Bupleurum species. 
In brief, the fractionation method succeeds in the assessment 
of the antibacterial and antioxidant activity of B. lancifolium 
plant. Hence, the methanolic fraction extract has antioxidant 
potential with 33.03% of inhibition according to the Trolox 
standard antioxidant molecule, while n-hexane and methanol 
fractions showed powerful antibacterial activity against E. fae-
cium and S. sonnie strains with MIC 1.5625 mg/ml caused by 
both fractions.
CONCLUSION 
The aerial parts of B. lancifolium four solvents fractions (ace-
tone, n-hexane, methanol and aqueous) exert variable in-vitro 
antioxidant and antibacterial activities. The obtained results 
showed that the methanolic fraction has potent antioxidant ac-
tivity. Obviously, the methanol and n-hexane fractions affected 
the growth of E. faecium and S. sonnie bacterial strains. Further 
investigations such as isolation and identification of the active 
compounds are needed for the possible formulation of new 
therapeutic alternatives.
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